A Phase III,Randomized,Open Label Study Comparing Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa up to 2-3 Years for less than 45 Year Old Pre-menopausal Hormone Receptor-positive Breast Cancer

Trial Profile

A Phase III,Randomized,Open Label Study Comparing Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa up to 2-3 Years for less than 45 Year Old Pre-menopausal Hormone Receptor-positive Breast Cancer

Recruiting
Phase of Trial: Phase III

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Goserelin (Primary) ; Anthracyclines; Tamoxifen; Taxanes
  • Indications Breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 01 Dec 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top